Neutrophil to lymphocyte ratio as a predictor of response to neoadjuvant chemotherapy and survival in oesophageal adenocarcinoma.

Powell, A G M T; Chin, C; Coxon, A H; Chalishazar, A; Christian, A; Roberts, S A; Lewis, W G

Powell, A G M T; Chin, C; Coxon, A H; Chalishazar, A; Christian, A; Roberts, S A; Lewis, W G.

Affiliation

Powell AGMT; Division of Cancer and Genetics, Cardiff University, Cardiff, UK.
Chin C; Department of Surgery, University Hospital of Wales, Cardiff, UK.
Coxon AH; Department of Surgery, University Hospital of Wales, Cardiff, UK.
Chalishazar A; Department of Surgery, University Hospital of Wales, Cardiff, UK.
Christian A; Department of Surgery, University Hospital of Wales, Cardiff, UK.
Roberts SA; Department of Pathology, University Hospital of Wales, Cardiff, UK.
Lewis WG; Department of Radiology, University Hospital of Wales, Cardiff, UK.

BJS Open ; 4(3): 416-423, 2020 06.

Article de En | MEDLINE | ID: mdl-32232963

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'oesophage / Lymphocytes / Adénocarcinome / Traitement néoadjuvant / Granulocytes neutrophiles Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: BJS Open Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google